Concepedia

S Vadlamudi

SV

15

Publications

521

Citations

12

H-Index

1970

Active since

Affiliations

National Cancer Institute(Current)

S Vadlamudi is an author at National Cancer Institute specializing in medicine, pharmacology, and immunology.

Top concepts

MedicineImmunologyPharmacologyImmunotherapyCancer ResearchTumor BiologyPharmacotherapyOncologyCell BiologyTumor Immunity

Publications per year

1970–1976

15

Publications

15

IMMUNOLOGICAL ALTERNATION OF LEUKEMIC CELLS <i>In Vivo</i> AFTER TREATMENT WITH AN ANTITUMOR DRUG

Enzo Bonmassar, Anna Bonmassar, S Vadlamudi et al. · Proceedings of the National Academy of Sciences · 1970 · 121 citations · Full text

Cell Therapy, L1210 Leukemia, Generalized Leukemia +17

Antigenic changes of L1210 leukemia in mice treated with 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide.

Enzo Bonmassar, Anna Bonmassar, S Vadlamudi et al. · PubMed · 1972 · 71 citations

Hematological Malignancy, Cancer Immunosurveillance, Allergy +15

Antigenicity of L1210 leukemic sublines induced by drugs.

A Nicolin, S Vadlamudi, Abraham Goldin · PubMed · 1972 · 63 citations

Hematological Malignancy, Lymphoid Neoplasia, Leukemia L1210 +12

Synthesis and biologic evaluation of 7-hydroxymethotrexate, 7-methylaminopterin, and 7-methylmethotrexate

David Farquhar, Ti Li Loo, S Vadlamudi · Journal of Medicinal Chemistry · 1972 · 48 citations

Pharmaceutical Science, Biologic Evaluation, Altmetric Attention Score +16

Effect of combination treatment with cyclophosphamide and isogeneic or allogeneic spleen and bone marrow cells in leukemic (l1210) mice

S Vadlamudi, M Padarathsingh, Enzo Bonmassar et al. · International Journal of Cancer · 1971 · 34 citations

Cell Therapy, Immunology, Immune Regulation +20

Rows per page

1–5 of 15